FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Sci / Atopic Dermatitis in Domestic Animals: What Our Current Unde...
Veterinary sciences2021; 8(7); 124; doi: 10.3390/vetsci8070124

Atopic Dermatitis in Domestic Animals: What Our Current Understanding Is and How This Applies to Clinical Practice.

Abstract: Atopic dermatitis is a clinical syndrome that affects both people and animals. Dogs closely mimic the complexity of the human skin disease, and much progress has been made in recent years in terms of our understanding of the role of skin impairment and the identification of new treatments. Cats and horses also develop atopic syndromes which include both cutaneous and respiratory signs, yet studies in these species are lagging. It is now recognized that atopic dermatitis is not a single disease but a multifaceted clinical syndrome with different pathways in various subgroups of patients. Appreciating this complexity is clinically relevant as we develop more targeted treatments which may work well in some patients but not in others. Different phenotypes of atopic dermatitis have been described in dogs, and it is possible that phenotypes related to breed and age may exist in other animals similar to how they are described in people. The awareness of different mechanisms of disease leads to the desire to correlate different phenotypes with specific biomarkers and responses to treatment. In this review, the current understanding and updated information on atopic syndrome in animals are described, highlighting opportunities for further studies in the future.
Get Full Text
Publication Date: 2021-07-02 PubMed ID: 34357916PubMed Central: PMC8310319DOI: 10.3390/vetsci8070124Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the progress made in understanding atopic dermatitis in domestic animals, such as dogs, cats, and horses, and how this knowledge can influence clinical practices. It emphasizes that atopic dermatitis is a complex disease with different pathways in various patient subgroups and the possibility of breed and age-related phenotypes.

Research Overview

The article primarily focuses on the clinical syndrome of atopic dermatitis, a condition affecting both people and animals. This study draws attention to the similarities of the disease progression in dogs to their human counterparts, highlighting the complexity involved. The researchers have explored significant advancements in understanding the effects of dermatitis, particularly skin impairment, and identifying new treatments.

Atopic Syndromes in Cats and Horses

  • The study recognizes that, like dogs, cats and horses also develop atopic syndromes. These syndromes encompass both cutaneous (skin-related) and respiratory signs.
  • Despite these implications, the research in these species hasn’t progressed at the same rate as that in canine counterparts. The article suggests opportunities for further studies to understand these complex syndromes better in cats and horses.

Complexity of Atopic Dermatitis

  • The article emphasizes that atopic dermatitis is not a simple, singular disease. Instead, it’s a multifaceted clinical syndrome affecting different subgroups of patients differently.
  • Understanding this nuance is crucial in clinical practice, as some treatments developed might work effectively for certain patients but not for others. This differential effectiveness is attributed to varying disease pathways among different patient groups.

Atopic Dermatitis Phenotypes

  • Various phenotypes (observable characteristics) of atopic dermatitis have been identified in dogs by the researchers. They also suggest the possibility of similar, breed, and age-related phenotypes existing in other animals, something commonly observed in people.
  • The researchers indicate a growing desire to connect different disease phenotypes with unique biomarkers (biological markers) and treatment responses, thereby personalizing the treatment strategies based on specific patient categories.

Conclusion

This research review presents an updated perspective on our understanding of atopic syndromes in animals. The authors hope that their study will cast light on promising areas for future investigation and contribute to more targeted and effective treatment strategies in veterinary medicine.

Cite This Article

APA
Marsella R. (2021). Atopic Dermatitis in Domestic Animals: What Our Current Understanding Is and How This Applies to Clinical Practice. Vet Sci, 8(7), 124. https://doi.org/10.3390/vetsci8070124

Publication

Veterinary sciences
ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 8
Issue: 7
PII: 124

Researcher Affiliations

Marsella, Rosanna
  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610, USA.

Conflict of Interest Statement

Marsella has received multiple pharma research funding.

References

This article includes 142 references
  1. Paller AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march and atopic multimorbidity: Many trajectories, many pathways.. J Allergy Clin Immunol 2019 Jan;143(1):46-55.
    doi: 10.1016/j.jaci.2018.11.006pubmed: 30458183google scholar: lookup
  2. Arcique MA, Bajwa J. Atopic dermatitis in humans and dogs.. Can Vet J 2020 Jan;61(1):82-84.
    pmc: PMC6909410pubmed: 31892761
  3. Marsella R, De Benedetto A. Atopic Dermatitis in Animals and People: An Update and Comparative Review.. Vet Sci 2017 Jul 26;4(3).
    doi: 10.3390/vetsci4030037pmc: PMC5644664pubmed: 29056696google scholar: lookup
  4. Rudolph K, Yellowhair TR, Dearing JJ, Barrett EG. Durability of the atopic dermatitis phenotype in a laboratory colony of beagles.. Vet. Dermatol. 2020;31:60.
  5. Nuttall TJ, Marsella R, Rosenbaum MR, Gonzales AJ, Fadok VA. Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs.. J Am Vet Med Assoc 2019 Jun 1;254(11):1291-1300.
    doi: 10.2460/javma.254.11.1291pubmed: 31067173google scholar: lookup
  6. Marsella R, Olivry T, Nicklin C, Lopez J. Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs.. Vet Dermatol 2006 Feb;17(1):24-35.
    doi: 10.1111/j.1365-3164.2005.00496.xpubmed: 16412117google scholar: lookup
  7. Pucheu-Haston CM, Jackson HA, Olivry T, Dunston SM, Hammerberg B. Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis.. Clin Exp Allergy 2008 Apr;38(4):667-79.
    doi: 10.1111/j.1365-2222.2008.02949.xpubmed: 18307530google scholar: lookup
  8. Olivry T, Mayhew D, Paps JS, Linder KE, Peredo C, Rajpal D, Hofland H, Cote-Sierra J. Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions.. J Invest Dermatol 2016 Oct;136(10):1961-1969.
    doi: 10.1016/j.jid.2016.05.117pubmed: 27342734google scholar: lookup
  9. Marsella R. Advances in our understanding of canine atopic dermatitis.. Vet Dermatol 2021 Dec;32(6):547-e151.
    doi: 10.1111/vde.12965pubmed: 33891338google scholar: lookup
  10. Pucheu-Haston CM, Bizikova P, Eisenschenk MN, Santoro D, Nuttall T, Marsella R. Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis.. Vet Dermatol 2015 Apr;26(2):115-e30.
    doi: 10.1111/vde.12201pubmed: 25728611google scholar: lookup
  11. Santoro D, Marsella R, Pucheu-Haston CM, Eisenschenk MN, Nuttall T, Bizikova P. Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.. Vet Dermatol 2015 Apr;26(2):84-e25.
    doi: 10.1111/vde.12197pubmed: 25683702google scholar: lookup
  12. Pucheu-Haston CM, Bizikova P, Marsella R, Santoro D, Nuttall T, Eisenschenk MN. Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis.. Vet Dermatol 2015 Apr;26(2):124-e32.
    doi: 10.1111/vde.12205pubmed: 25808535google scholar: lookup
  13. Früh SP, Saikia M, Eule J, Mazulis CA, Miller JE, Cowulich JM, Oyesola OO, Webb LM, Peng SA, Cubitt RL, Danko CG, Miller WH, Tait Wojno ED. Elevated circulating Th2 but not group 2 innate lymphoid cell responses characterize canine atopic dermatitis.. Vet Immunol Immunopathol 2020 Mar;221:110015.
    doi: 10.1016/j.vetimm.2020.110015pubmed: 32058160google scholar: lookup
  14. Jassies-van der Lee A, Rutten VP, Bruijn J, Willemse T, Broere F. CD4+ and CD8+ skin-associated T lymphocytes in canine atopic dermatitis produce interleukin-13, interleukin-22 and interferon-γ and contain a CD25+ FoxP3+ subset.. Vet Dermatol 2014 Oct;25(5):456-e72.
    doi: 10.1111/vde.12140pubmed: 24913127google scholar: lookup
  15. Saridomichelakis MN, Olivry T. An update on the treatment of canine atopic dermatitis.. Vet J 2016 Jan;207:29-37.
    doi: 10.1016/j.tvjl.2015.09.016pubmed: 26586215google scholar: lookup
  16. Hsiao YH, Chen C, Willemse T. Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.. J Vet Sci 2016 Dec 30;17(4):549-553.
    doi: 10.4142/jvs.2016.17.4.549pmc: PMC5204033pubmed: 27297415google scholar: lookup
  17. Zur G, Ihrke PJ, White SD, Kass PH. Antihistamines in the management of canine atopic dermatitis: a retrospective study of 171 dogs (1992-1998).. Vet Ther 2002 Spring;3(1):88-96.
    pubmed: 12050832
  18. Marsella R, Segarra S, Ahrens K, Alonso C, Ferrer L. Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.. BMC Vet Res 2020 Mar 20;16(1):92.
    doi: 10.1186/s12917-020-02306-6pmc: PMC7082980pubmed: 32197613google scholar: lookup
  19. Blaskovic M, Rosenkrantz W, Neuber A, Sauter-Louis C, Mueller RS. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.. Vet J 2014 Jan;199(1):39-43.
    doi: 10.1016/j.tvjl.2013.10.024pubmed: 24355814google scholar: lookup
  20. Tretter S, Mueller RS. The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs.. J Am Anim Hosp Assoc 2011 Jul-Aug;47(4):236-40.
    doi: 10.5326/JAAHA-MS-5607pubmed: 21673338google scholar: lookup
  21. Jeffers JG. Topical therapy for drug-resistant pyoderma in small animals.. Vet Clin North Am Small Anim Pract 2013 Jan;43(1):41-50.
    doi: 10.1016/j.cvsm.2012.09.006pubmed: 23182323google scholar: lookup
  22. Loeffler A, Lloyd DH. What has changed in canine pyoderma? A narrative review.. Vet J 2018 May;235:73-82.
    doi: 10.1016/j.tvjl.2018.04.002pubmed: 29704943google scholar: lookup
  23. Hensel P, Santoro D, Favrot C, Hill P, Griffin C. Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification.. BMC Vet Res 2015 Aug 11;11:196.
    doi: 10.1186/s12917-015-0515-5pmc: PMC4531508pubmed: 26260508google scholar: lookup
  24. Piccione ML, DeBoer DJ. Serum IgE against cross-reactive carbohydrate determinants (CCD) in healthy and atopic dogs.. Vet Dermatol 2019 Dec;30(6):507-e153.
    doi: 10.1111/vde.12799pubmed: 31642119google scholar: lookup
  25. Favrot C, Steffan J, Seewald W, Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis.. Vet Dermatol 2010 Feb;21(1):23-31.
    doi: 10.1111/j.1365-3164.2009.00758.xpubmed: 20187911google scholar: lookup
  26. Olivry T, Deboer DJ, Prélaud P, Bensignor E. Food for thought: pondering the relationship between canine atopic dermatitis and cutaneous adverse food reactions.. Vet Dermatol 2007 Dec;18(6):390-1.
    doi: 10.1111/j.1365-3164.2007.00625.xpubmed: 17991155google scholar: lookup
  27. Botoni LS, Torres SMF, Koch SN, Heinemann MB, Costa-Val AP. Comparison of demographic data, disease severity and response to treatment, between dogs with atopic dermatitis and atopic-like dermatitis: a retrospective study.. Vet Dermatol 2019 Feb;30(1):10-e4.
    doi: 10.1111/vde.12708pubmed: 30536460google scholar: lookup
  28. Marsella R, Olivry T, Carlotti DN. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.. Vet Dermatol 2011 Jun;22(3):239-48.
    doi: 10.1111/j.1365-3164.2011.00967.xpubmed: 21414049google scholar: lookup
  29. Olivry T, Wofford J, Paps JS, Dunston SM. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs.. Vet Dermatol 2011 Apr;22(2):188-96.
    doi: 10.1111/j.1365-3164.2010.00938.xpubmed: 21143539google scholar: lookup
  30. Olivry T, Deangelo KB, Dunston SM, Clarke KB, McCall CA. Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis.. Vet Dermatol 2006 Apr;17(2):95-102.
    doi: 10.1111/j.1365-3164.2006.00502.xpubmed: 16515651google scholar: lookup
  31. Marsella R. Experimental model for peanut allergy by epicutaneous sensitization in atopic beagle dogs.. Exp Dermatol 2015 Sep;24(9):711-2.
    doi: 10.1111/exd.12776pubmed: 26014917google scholar: lookup
  32. Marsella R, Nicklin C, Lopez J. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites.. Vet Dermatol 2006 Oct;17(5):306-12.
    doi: 10.1111/j.1365-3164.2006.00541.xpubmed: 16961815google scholar: lookup
  33. Olivry T, Dunston SM. Expression patterns of superficial epidermal adhesion molecules in an experimental dog model of acute atopic dermatitis skin lesions.. Vet Dermatol 2015 Feb;26(1):53-6, e-17-8.
    doi: 10.1111/vde.12188pubmed: 25496350google scholar: lookup
  34. Cobiella D, Archer L, Bohannon M, Santoro D. Pilot study using five methods to evaluate skin barrier function in healthy dogs and in dogs with atopic dermatitis.. Vet Dermatol 2019 Jan 15;.
    doi: 10.1111/vde.12723pubmed: 30644144google scholar: lookup
  35. Theerawatanasirikul S, Sailasuta A, Thanawongnuwech R, Suriyaphol G. Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis.. Res Vet Sci 2012 Dec;93(3):1287-92.
    doi: 10.1016/j.rvsc.2012.06.005pubmed: 22784629google scholar: lookup
  36. Santoro D, Marsella R, Ahrens K, Graves TK, Bunick D. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.. Vet Dermatol 2013 Jun;24(3):329-36, e73.
    doi: 10.1111/vde.12031pubmed: 23668858google scholar: lookup
  37. Drislane C, Irvine AD. The role of filaggrin in atopic dermatitis and allergic disease.. Ann Allergy Asthma Immunol 2020 Jan;124(1):36-43.
    doi: 10.1016/j.anai.2019.10.008pubmed: 31622670google scholar: lookup
  38. Cabanillas B, Novak N. Atopic dermatitis and filaggrin.. Curr Opin Immunol 2016 Oct;42:1-8.
    doi: 10.1016/j.coi.2016.05.002pubmed: 27206013google scholar: lookup
  39. Combarros D, Cadiergues MC, Simon M. Update on canine filaggrin: a review.. Vet Q 2020 Dec;40(1):162-168.
    doi: 10.1080/01652176.2020.1758357pmc: PMC7241532pubmed: 32308144google scholar: lookup
  40. Wood SH, Ollier WE, Nuttall T, McEwan NA, Carter SD. Despite identifying some shared gene associations with human atopic dermatitis the use of multiple dog breeds from various locations limits detection of gene associations in canine atopic dermatitis.. Vet Immunol Immunopathol 2010 Dec 1;138(3):193-7.
    doi: 10.1016/j.vetimm.2010.07.020pubmed: 20728225google scholar: lookup
  41. Wood SH, Clements DN, Ollier WE, Nuttall T, McEwan NA, Carter SD. Gene expression in canine atopic dermatitis and correlation with clinical severity scores.. J Dermatol Sci 2009 Jul;55(1):27-33.
    doi: 10.1016/j.jdermsci.2009.03.005pubmed: 19394200google scholar: lookup
  42. Wood SH, Ke X, Nuttall T, McEwan N, Ollier WE, Carter SD. Genome-wide association analysis of canine atopic dermatitis and identification of disease related SNPs.. Immunogenetics 2009 Dec;61(11-12):765-72.
    doi: 10.1007/s00251-009-0402-ypubmed: 19838693google scholar: lookup
  43. Fanton N, Santoro D, Cornegliani L, Marsella R. Increased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.. Vet Dermatol 2017 Oct;28(5):479-e111.
    doi: 10.1111/vde.12443pubmed: 28393458google scholar: lookup
  44. Proksch E. pH in nature, humans and skin.. J Dermatol 2018 Sep;45(9):1044-1052.
    doi: 10.1111/1346-8138.14489pubmed: 29863755google scholar: lookup
  45. Bizikova P, Pucheu-Haston CM, Eisenschenk MN, Marsella R, Nuttall T, Santoro D. Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis.. Vet Dermatol 2015 Apr;26(2):95-e26.
    doi: 10.1111/vde.12198pubmed: 25703290google scholar: lookup
  46. Nuttall T. The genomics revolution: will canine atopic dermatitis be predictable and preventable?. Vet Dermatol 2013 Feb;24(1):10-8.e3-4.
    doi: 10.1111/j.1365-3164.2012.01094.xpubmed: 23331674google scholar: lookup
  47. Flohr C, Yeo L. Atopic dermatitis and the hygiene hypothesis revisited.. Curr Probl Dermatol 2011;41:1-34.
    doi: 10.1159/000323290pubmed: 21576944google scholar: lookup
  48. Rutkowski K, Sowa P, Rutkowska-Talipska J, Sulkowski S, Rutkowski R. Allergic diseases: the price of civilisational progress.. Postepy Dermatol Alergol 2014 May;31(2):77-83.
    doi: 10.5114/pdia.2014.40936pmc: PMC4112251pubmed: 25097472google scholar: lookup
  49. Hemida M, Vuori KA, Salin S, Moore R, Anturaniemi J, Hielm-Björkman A. Identification of modifiable pre- and postnatal dietary and environmental exposures associated with owner-reported canine atopic dermatitis in Finland using a web-based questionnaire.. PLoS One 2020;15(5):e0225675.
    doi: 10.1371/journal.pone.0225675pmc: PMC7259748pubmed: 32469869google scholar: lookup
  50. Anturaniemi J, Zaldívar-López S, Savelkoul HFJ, Elo K, Hielm-Björkman A. The Effect of Atopic Dermatitis and Diet on the Skin Transcriptome in Staffordshire Bull Terriers.. Front Vet Sci 2020;7:552251.
    doi: 10.3389/fvets.2020.552251pmc: PMC7596200pubmed: 33178726google scholar: lookup
  51. Anturaniemi J, Uusitalo L, Hielm-Björkman A. Environmental and phenotype-related risk factors for owner-reported allergic/atopic skin symptoms and for canine atopic dermatitis verified by veterinarian in a Finnish dog population.. PLoS One 2017;12(6):e0178771.
    doi: 10.1371/journal.pone.0178771pmc: PMC5453595pubmed: 28570617google scholar: lookup
  52. Harvey ND, Shaw SC, Craigon PJ, Blott SC, England GCW. Environmental risk factors for canine atopic dermatitis: a retrospective large-scale study in Labrador and golden retrievers.. Vet Dermatol 2019 Oct;30(5):396-e119.
    doi: 10.1111/vde.12782pubmed: 31407839google scholar: lookup
  53. Cabanillas B, Brehler AC, Novak N. Atopic dermatitis phenotypes and the need for personalized medicine.. Curr Opin Allergy Clin Immunol 2017 Aug;17(4):309-315.
    doi: 10.1097/ACI.0000000000000376pmc: PMC5515628pubmed: 28582322google scholar: lookup
  54. Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics.. J Allergy Clin Immunol 2019 Jan;143(1):1-11.
    doi: 10.1016/j.jaci.2018.10.032pubmed: 30612663google scholar: lookup
  55. Roduit C, Frei R, Depner M, Karvonen AM, Renz H, Braun-Fahrländer C, Schmausser-Hechfellner E, Pekkanen J, Riedler J, Dalphin JC, von Mutius E, Lauener RP, Hyvärinen A, Kirjavainen P, Remes S, Roponen M, Dalphin ML, Kaulek V, Ege M, Genuneit J, Illi S, Kabesch M, Schaub B, Pfefferle PI, Doekes G. Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood.. JAMA Pediatr 2017 Jul 1;171(7):655-662.
    doi: 10.1001/jamapediatrics.2017.0556pmc: PMC5710337pubmed: 28531273google scholar: lookup
  56. Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis.. Ann Allergy Asthma Immunol 2019 May;122(5):449-455.
    doi: 10.1016/j.anai.2018.11.015pubmed: 30465859google scholar: lookup
  57. Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment.. Exp Dermatol 2018 Apr;27(4):340-357.
    doi: 10.1111/exd.13514pubmed: 29457272google scholar: lookup
  58. Noda S, Suárez-Fariñas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H, Peng X, Estrada YD, Nakajima S, Honda T, Shin JU, Lee H, Krueger JG, Lee KH, Kabashima K, Guttman-Yassky E. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.. J Allergy Clin Immunol 2015 Nov;136(5):1254-64.
    doi: 10.1016/j.jaci.2015.08.015pubmed: 26428954google scholar: lookup
  59. Wilhem S, Kovalik M, Favrot C. Breed-associated phenotypes in canine atopic dermatitis.. Vet Dermatol 2011 Apr;22(2):143-9.
    doi: 10.1111/j.1365-3164.2010.00925.xpubmed: 20887404google scholar: lookup
  60. Chaudhary SK, Singh SK, Kumari P, Kanwal S, Soman SP, Choudhury S, Garg SK. Alterations in circulating concentrations of IL-17, IL-31 and total IgE in dogs with atopic dermatitis.. Vet Dermatol 2019 Oct;30(5):383-e114.
    doi: 10.1111/vde.12762pubmed: 31218782google scholar: lookup
  61. Cornelissen C, Lüscher-Firzlaff J, Baron JM, Lüscher B. Signaling by IL-31 and functional consequences.. Eur J Cell Biol 2012 Jun-Jul;91(6-7):552-66.
    doi: 10.1016/j.ejcb.2011.07.006pubmed: 21982586google scholar: lookup
  62. Gonzales AJ, Humphrey WR, Messamore JE, Fleck TJ, Fici GJ, Shelly JA, Teel JF, Bammert GF, Dunham SA, Fuller TE, McCall RB. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis.. Vet Dermatol 2013 Feb;24(1):48-53.e11-2.
    doi: 10.1111/j.1365-3164.2012.01098.xpubmed: 23331679google scholar: lookup
  63. Cornelissen C, Marquardt Y, Czaja K, Wenzel J, Frank J, Lüscher-Firzlaff J, Lüscher B, Baron JM. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models.. J Allergy Clin Immunol 2012 Feb;129(2):426-33, 433.e1-8.
    doi: 10.1016/j.jaci.2011.10.042pubmed: 22177328google scholar: lookup
  64. Moyaert H, Van Brussel L, Borowski S, Escalada M, Mahabir SP, Walters RR, Stegemann MR. A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.. Vet Dermatol 2017 Dec;28(6):593-e145.
    doi: 10.1111/vde.12478pubmed: 28906040google scholar: lookup
  65. Bachmann MF, Zeltins A, Kalnins G, Balke I, Fischer N, Rostaher A, Tars K, Favrot C. Vaccination against IL-31 for the treatment of atopic dermatitis in dogs.. J Allergy Clin Immunol 2018 Jul;142(1):279-281.e1.
    doi: 10.1016/j.jaci.2017.12.994pubmed: 29627081google scholar: lookup
  66. Wollenberg A, Ehmann LM. Long term treatment concepts and proactive therapy for atopic eczema.. Ann Dermatol 2012 Aug;24(3):253-60.
    doi: 10.5021/ad.2012.24.3.253pmc: PMC3412232pubmed: 22879707google scholar: lookup
  67. Lourenço AM, Schmidt V, São Braz B, Nóbrega D, Nunes T, Duarte-Correia JH, Matias D, Maruhashi E, Rème CA, Nuttall T. Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.. Vet Dermatol 2016 Apr;27(2):88-92e25.
    doi: 10.1111/vde.12285pubmed: 26804943google scholar: lookup
  68. Tamamoto-Mochizuki C, Paps JS, Olivry T. Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmab. Can a monoclonal antibody blocking a single cytokine prevent allergy flares?. Vet Dermatol 2019 Jan 23;.
    doi: 10.1111/vde.12715pubmed: 30672050google scholar: lookup
  69. Mueller RS. Update on Allergen Immunotherapy.. Vet Clin North Am Small Anim Pract 2019 Jan;49(1):1-7.
    doi: 10.1016/j.cvsm.2018.08.001pubmed: 30227970google scholar: lookup
  70. DeBoer DJ, Verbrugge M, Morris M. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).. Vet Dermatol 2016 Apr;27(2):82-7e23.
    doi: 10.1111/vde.12284pubmed: 26749020google scholar: lookup
  71. DeBoer DJ. The future of immunotherapy for canine atopic dermatitis: a review.. Vet Dermatol 2017 Feb;28(1):25-e6.
    doi: 10.1111/vde.12416pubmed: 28133873google scholar: lookup
  72. Fischer NM, Rostaher A, Favrot C. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.. Vet Dermatol 2020 Oct;31(5):365-e96.
    doi: 10.1111/vde.12860pubmed: 32537789google scholar: lookup
  73. Martins GC, de Oliveira Melo Júnior OA, Botoni LS, Nogueira MM, da Costa Val AP, Blanco BS, Dutra WO, Giunchetti RC, Melo MM, da Silveira Lemos D. Clinical-pathological and immunological biomarkers in dogs with atopic dermatitis.. Vet Immunol Immunopathol 2018 Nov;205:58-64.
    doi: 10.1016/j.vetimm.2018.10.009pubmed: 30459002google scholar: lookup
  74. Klukowska-Rötzler J, Chervet L, Müller EJ, Roosje P, Marti E, Janda J. Expression of thymic stromal lymphopoietin in canine atopic dermatitis.. Vet Dermatol 2013 Feb;24(1):54-9.e13-4.
    doi: 10.1111/j.1365-3164.2012.01096.xpubmed: 23331680google scholar: lookup
  75. Asahina R, Ueda K, Oshima Y, Kanei T, Kato M, Furue M, Tsukui T, Nagata M, Maeda S. Serum canine thymus and activation-regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis.. Vet Dermatol 2020 Dec;31(6):446-455.
    doi: 10.1111/vde.12894pmc: PMC7756442pubmed: 32945018google scholar: lookup
  76. Asahina R, Nishida H, Kamishina H, Maeda S. Expression of IL-33 in chronic lesional skin of canine atopic dermatitis.. Vet Dermatol 2018 Jun;29(3):246-e91.
    doi: 10.1111/vde.12531pubmed: 29498117google scholar: lookup
  77. Gow DJ, Jackson H, Forsythe P, Nuttall T, Gow AG, Mellanby RJ, Hume DA. Measurement of serum Interleukin 34 (IL-34) and correlation with severity and pruritus scores in client-owned dogs with atopic dermatitis.. Vet Dermatol 2020 Oct;31(5):359-e94.
    doi: 10.1111/vde.12873pubmed: 32794277google scholar: lookup
  78. Mineshige T, Kamiie J, Sugahara G, Shirota K. A study on periostin involvement in the pathophysiology of canine atopic skin.. J Vet Med Sci 2018 Jan 27;80(1):103-111.
    doi: 10.1292/jvms.17-0453pmc: PMC5797867pubmed: 29176263google scholar: lookup
  79. Mishra SK, Wheeler JJ, Pitake S, Ding H, Jiang C, Fukuyama T, Paps JS, Ralph P, Coyne J, Parkington M, DeBrecht J, Ehrhardt-Humbert LC, Cruse GP, Bäumer W, Ji RR, Ko MC, Olivry T. Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch.. Cell Rep 2020 Apr 7;31(1):107472.
    doi: 10.1016/j.celrep.2020.03.036pubmed: 32268102google scholar: lookup
  80. Mineshige T, Kamiie J, Sugahara G, Yasuno K, Aihara N, Kawarai S, Yamagishi K, Shirota M, Shirota K. Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin.. Vet Pathol 2015 Nov;52(6):1118-26.
    doi: 10.1177/0300985815574007pubmed: 25755133google scholar: lookup
  81. Laprais A, Dunston SM, Torres SMF, Favrot C, Olivry T. Evaluation of intraepidermal nerve fibres in the skin of normal and atopic dogs.. Vet Dermatol 2017 Aug;28(4):355-e80.
    doi: 10.1111/vde.12420pubmed: 28133844google scholar: lookup
  82. Tizard IR, Jones SW. The Microbiota Regulates Immunity and Immunologic Diseases in Dogs and Cats.. Vet Clin North Am Small Anim Pract 2018 Mar;48(2):307-322.
    doi: 10.1016/j.cvsm.2017.10.008pubmed: 29198905google scholar: lookup
  83. Bradley CW, Morris DO, Rankin SC, Cain CL, Misic AM, Houser T, Mauldin EA, Grice EA. Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis.. J Invest Dermatol 2016 Jun;136(6):1182-1190.
    doi: 10.1016/j.jid.2016.01.023pmc: PMC4877200pubmed: 26854488google scholar: lookup
  84. Pierezan F, Olivry T, Paps JS, Lawhon SD, Wu J, Steiner JM, Suchodolski JS, Rodrigues Hoffmann A. The skin microbiome in allergen-induced canine atopic dermatitis.. Vet Dermatol 2016 Oct;27(5):332-e82.
    doi: 10.1111/vde.12366pubmed: 27485242google scholar: lookup
  85. Meason-Smith C, Diesel A, Patterson AP, Older CE, Mansell JM, Suchodolski JS, Rodrigues Hoffmann A. What is living on your dog's skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis.. FEMS Microbiol Ecol 2015 Dec;91(12).
    doi: 10.1093/femsec/fiv139pmc: PMC4657189pubmed: 26542075google scholar: lookup
  86. Chermprapai S, Ederveen THA, Broere F, Broens EM, Schlotter YM, van Schalkwijk S, Boekhorst J, van Hijum SAFT, Rutten VPMG. The bacterial and fungal microbiome of the skin of healthy dogs and dogs with atopic dermatitis and the impact of topical antimicrobial therapy, an exploratory study.. Vet Microbiol 2019 Feb;229:90-99.
    doi: 10.1016/j.vetmic.2018.12.022pubmed: 30642603google scholar: lookup
  87. Myles IA, Earland NJ, Anderson ED, Moore IN, Kieh MD, Williams KW, Saleem A, Fontecilla NM, Welch PA, Darnell DA, Barnhart LA, Sun AA, Uzel G, Datta SK. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.. JCI Insight 2018 May 3;3(9).
    doi: 10.1172/jci.insight.120608pmc: PMC6012572pubmed: 29720571google scholar: lookup
  88. Hendricks AJ, Mills BW, Shi VY. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends.. J Dermatol Sci 2019 Aug;95(2):56-61.
    doi: 10.1016/j.jdermsci.2019.07.001pubmed: 31395434google scholar: lookup
  89. Marsella R, Santoro D, Ahrens K. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.. Vet Immunol Immunopathol 2012 Apr 15;146(2):185-9.
    doi: 10.1016/j.vetimm.2012.02.013pubmed: 22436376google scholar: lookup
  90. Ohshima-Terada Y, Higuchi Y, Kumagai T, Hagihara A, Nagata M. Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis.. Vet Dermatol 2015 Oct;26(5):350-3, e74-5.
    doi: 10.1111/vde.12224pubmed: 26123498google scholar: lookup
  91. Halliwell R, Pucheu-Haston CM, Olivry T, Prost C, Jackson H, Banovic F, Nuttall T, Santoro D, Bizikova P, Mueller RS. Feline allergic diseases: introduction and proposed nomenclature.. Vet Dermatol 2021 Feb;32(1):8-e2.
    doi: 10.1111/vde.12899pubmed: 33470016google scholar: lookup
  92. Halliwell R, Banovic F, Mueller RS, Olivry T. Immunopathogenesis of the feline atopic syndrome.. Vet Dermatol 2021 Feb;32(1):13-e4.
    doi: 10.1111/vde.12928pubmed: 33470018google scholar: lookup
  93. Seals SL, Kearney M, Del Piero F, Hammerberg B, Pucheu-Haston CM. A study for characterization of IgE-mediated cutaneous immediate and late-phase reactions in non-allergic domestic cats.. Vet Immunol Immunopathol 2014 May 15;159(1-2):41-9.
    doi: 10.1016/j.vetimm.2014.02.007pubmed: 24629765google scholar: lookup
  94. van Eeden ME, Vientós-Plotts AI, Cohn LA, Reinero CR. Serum allergen-specific IgE reactivity: is there an association with clinical severity and airway eosinophilia in asthmatic cats?. J Feline Med Surg 2020 Dec;22(12):1129-1136.
    doi: 10.1177/1098612X20907178pubmed: 32167403google scholar: lookup
  95. Diesel A. Cutaneous Hypersensitivity Dermatoses in the Feline Patient: A Review of Allergic Skin Disease in Cats.. Vet Sci 2017 May 9;4(2).
    doi: 10.3390/vetsci4020025pmc: PMC5606602pubmed: 29056684google scholar: lookup
  96. Szczepanik MP, Wilkołek PM, Adamek ŁR, Kalisz G, Gołyński M, Sitkowski W, Taszkun I. Transepidermal water loss and skin hydration in healthy cats and cats with non-flea non-food hypersensitivity dermatitis (NFNFHD).. Pol J Vet Sci 2019 Jun;22(2):237-242.
    pubmed: 31269340doi: 10.24425/pjvs.2019.127091google scholar: lookup
  97. Szczepanik MP, Wilkołek PM, Adamek ŁR, Zając M, Gołyński M, Sitkowski W, Taszkun I. Evaluation of the correlation between Scoring Feline Allergic Dermatitis and Feline Extent and Severity Index and skin hydration in atopic cats.. Vet Dermatol 2018 Feb;29(1):34-e16.
    doi: 10.1111/vde.12489pubmed: 28901591google scholar: lookup
  98. Roosje PJ, van Kooten PJ, Thepen T, Bihari IC, Rutten VP, Koeman JP, Willemse T. Increased numbers of CD4+ and CD8+ T cells in lesional skin of cats with allergic dermatitis.. Vet Pathol 1998 Jul;35(4):268-73.
    doi: 10.1177/030098589803500405pubmed: 9684970google scholar: lookup
  99. Roosje PJ, Dean GA, Willemse T, Rutten VP, Thepen T. Interleukin 4-producing CD4+ T cells in the skin of cats with allergic dermatitis.. Vet Pathol 2002 Mar;39(2):228-33.
    doi: 10.1354/vp.39-2-228pubmed: 12009060google scholar: lookup
  100. Dunham S, Messamore J, Bessey L, Mahabir S, Gonzales AJ. Evaluation of circulating interleukin-31 levels in cats with a pre-sumptive diagnosis of allergic dermatitis.. Vet. Dermatol. 2018;29:284.
  101. Cheung PF, Wong CK, Ho AW, Hu S, Chen DP, Lam CW. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis.. Int Immunol 2010 Jun;22(6):453-67.
    doi: 10.1093/intimm/dxq027pubmed: 20410259google scholar: lookup
  102. Hobi S, Linek M, Marignac G, Olivry T, Beco L, Nett C, Fontaine J, Roosje P, Bergvall K, Belova S, Koebrich S, Pin D, Kovalik M, Meury S, Wilhelm S, Favrot C. Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity-associated dermatoses.. Vet Dermatol 2011 Oct;22(5):406-13.
    doi: 10.1111/j.1365-3164.2011.00962.xpubmed: 21410570google scholar: lookup
  103. Favrot C. Feline non-flea induced hypersensitivity dermatitis: clinical features, diagnosis and treatment.. J Feline Med Surg 2013 Sep;15(9):778-84.
    doi: 10.1177/1098612X13500427pubmed: 23966004google scholar: lookup
  104. Dodds WJ. Diagnosis of Feline Food Sensitivity and Intolerance Using Saliva: 1000 Cases.. Animals (Basel) 2019 Aug 6;9(8).
    doi: 10.3390/ani9080534pmc: PMC6719944pubmed: 31390763google scholar: lookup
  105. Mueller RS, Unterer S. Adverse food reactions: Pathogenesis, clinical signs, diagnosis and alternatives to elimination diets.. Vet J 2018 Jun;236:89-95.
    doi: 10.1016/j.tvjl.2018.04.014pubmed: 29871756google scholar: lookup
  106. Belova S, Wilhelm S, Linek M, Beco L, Fontaine J, Bergvall K, Favrot C. Factors affecting allergen-specific IgE serum levels in cats.. Can J Vet Res 2012 Jan;76(1):45-51.
    pmc: PMC3244287pubmed: 22754094
  107. Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H. Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis.. Vet Dermatol 2021 Feb;32(1):26-e6.
    doi: 10.1111/vde.12935pubmed: 33470017google scholar: lookup
  108. Taglinger K, Helps CR, Day MJ, Foster AP. Measurement of serum immunoglobulin E (IgE) specific for house dust mite antigens in normal cats and cats with allergic skin disease.. Vet Immunol Immunopathol 2005 May 1;105(1-2):85-93.
    doi: 10.1016/j.vetimm.2004.12.017pubmed: 15797478google scholar: lookup
  109. Schleifer SG, Willemse T. Evaluation of skin test reactivity to environmental allergens in healthy cats and cats with atopic dermatitis.. Am J Vet Res 2003 Jun;64(6):773-8.
    doi: 10.2460/ajvr.2003.64.773pubmed: 12828264google scholar: lookup
  110. Lee KW, McKinney BH, Blankenship KD, Morris DO. Detection and Inhibition of IgE for cross-reactive carbohydrate determinants evident in an enzyme-linked immunosorbent assay for detection of allergen-specific IgE in the sera of dogs and cats.. Vet Dermatol 2020 Dec;31(6):439-e116.
    doi: 10.1111/vde.12904pmc: PMC7756665pubmed: 32975354google scholar: lookup
  111. Mueller RS, Nuttall T, Prost C, Schulz B, Bizikova P. Treatment of the feline atopic syndrome - a systematic review.. Vet Dermatol 2021 Feb;32(1):43-e8.
    doi: 10.1111/vde.12933pubmed: 33470011google scholar: lookup
  112. Scott DW, Miller WH. The combination of antihistamine (chlorpheniramine) and an omega-3/omega-6 fatty acid-containing product for the management of pruritic cats: results of an open clinical trial.. N Z Vet J 1995 Feb;43(1):29-31.
    doi: 10.1080/00480169.1995.35839pubmed: 16031799google scholar: lookup
  113. Ferrer L, Carrasco I, Cristòfol C, Puigdemont A. A pharmacokinetic study of oclacitinib maleate in six cats.. Vet Dermatol 2020 Apr;31(2):134-137.
    doi: 10.1111/vde.12819pubmed: 31769185google scholar: lookup
  114. Ortalda C, Noli C, Colombo S, Borio S. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.. Vet Dermatol 2015 Aug;26(4):235-e52.
    doi: 10.1111/vde.12218pubmed: 25940959google scholar: lookup
  115. Noli C, Matricoti I, Schievano C. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis.. Vet Dermatol 2019 Apr;30(2):110-e30.
    doi: 10.1111/vde.12720pubmed: 30656750google scholar: lookup
  116. Lee-Fowler TM, Cohn LA, DeClue AE, Spinka CM, Reinero CR. Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma.. Vet Immunol Immunopathol 2009 May 15;129(1-2):49-56.
    doi: 10.1016/j.vetimm.2008.12.008pubmed: 19144412google scholar: lookup
  117. Lee-Fowler TM, Cohn LA, DeClue AE, Spinka CM, Ellebracht RD, Reinero CR. Comparison of intradermal skin testing (IDST) and serum allergen-specific IgE determination in an experimental model of feline asthma.. Vet Immunol Immunopathol 2009 Nov 15;132(1):46-52.
    doi: 10.1016/j.vetimm.2009.09.014pubmed: 19819027google scholar: lookup
  118. Foj R, Carrasco I, Clemente F, Scarampella F, Calvet A, Prats A, Vivancos S, Brazís P, Puigdemont A. Clinical efficacy of sublingual allergen-specific immunotherapy in 22 cats with atopic dermatitis.. Vet Dermatol 2021 Feb;32(1):67-e12.
    doi: 10.1111/vde.12926pubmed: 33399258google scholar: lookup
  119. Medina-Cucurella AV, Bammert GF, Dunkle W, Javens C, Zhu Y, Mutchler VT, Teel JT, Stein CA, Dunham SA, Whitehead TA. Feline Interleukin-31 Shares Overlapping Epitopes with the Oncostatin M Receptor and IL-31RA.. Biochemistry 2020 Jun 16;59(23):2171-2181.
    doi: 10.1021/acs.biochem.0c00176pmc: PMC7379511pubmed: 32459958google scholar: lookup
  120. Verdon M, Lanz S, Rhyner C, Gerber V, Marti E. Allergen-specific immunoglobulin E in sera of horses affected with insect bite hypersensitivity, severe equine asthma or both conditions.. J Vet Intern Med 2019 Jan;33(1):266-274.
    doi: 10.1111/jvim.15355pmc: PMC6335542pubmed: 30520523google scholar: lookup
  121. Leclere M, Lavoie-Lamoureux A, Lavoie JP. Heaves, an asthma-like disease of horses.. Respirology 2011 Oct;16(7):1027-46.
    doi: 10.1111/j.1440-1843.2011.02033.xpubmed: 21824219google scholar: lookup
  122. Lorch G, Hillier A, Kwochka KW, Saville WA, LeRoy BE. Results of intradermal tests in horses without atopy and horses with atopic dermatitis or recurrent urticaria.. Am J Vet Res 2001 Jul;62(7):1051-9.
    doi: 10.2460/ajvr.2001.62.1051pubmed: 11453479google scholar: lookup
  123. Lorch G, Hillier A, Kwochka KW, Saville WJ, Kohn CW, Jose-Cunilleras E. Results of intradermal tests in horses without atopy and horses with chronic obstructive pulmonary disease.. Am J Vet Res 2001 Mar;62(3):389-97.
    doi: 10.2460/ajvr.2001.62.389pubmed: 11277205google scholar: lookup
  124. Radwanski NE, Morris DO, Boston RC, Cerundolo R, Lee KW. Longitudinal evaluation of immunological responses to allergen-specific immunotherapy in horses with IgE associated dermatological disease, a pilot study.. Vet Dermatol 2019 Jun;30(3):255-e78.
    doi: 10.1111/vde.12732pubmed: 30828914google scholar: lookup
  125. Gerber V, Swinburne JE, Blott SC, Nussbaumer P, Ramseyer A, Klukowska-Rötzler J, Dolf G, Marti E, Burger D, Leeb T. [Genetics of recurrent airway obstruction (RAO)].. Dtsch Tierarztl Wochenschr 2008 Jul;115(7):271-5.
    pubmed: 18672738
  126. Lanz S, Brunner A, Graubner C, Marti E, Gerber V. Insect Bite Hypersensitivity in Horses is Associated with Airway Hyperreactivity.. J Vet Intern Med 2017 Nov;31(6):1877-1883.
    doi: 10.1111/jvim.14817pmc: PMC5697210pubmed: 28921663google scholar: lookup
  127. Marsella R, Johnson C, Ahrens K. First case report of ultrastructural cutaneous abnormalities in equine atopic dermatitis.. Res Vet Sci 2014 Oct;97(2):382-5.
    doi: 10.1016/j.rvsc.2014.06.012pubmed: 25048836google scholar: lookup
  128. Cvitas I, Oberhänsli S, Leeb T, Dettwiler M, Müller E, Bruggman R, Marti EI. Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity.. PLoS One 2020;15(4):e0232189.
    doi: 10.1371/journal.pone.0232189pmc: PMC7188278pubmed: 32343720google scholar: lookup
  129. Jose-Cunilleras E, Kohn CW, Hillier A, Saville WJ, Lorch G. Intradermal testing in healthy horses and horses with chronic obstructive pulmonary disease, recurrent urticaria, or allergic dermatitis.. J Am Vet Med Assoc 2001 Oct 15;219(8):1115-21.
    doi: 10.2460/javma.2001.219.1115pubmed: 11700711google scholar: lookup
  130. Wilkołek PM, Pomorski ZJ, Szczepanik MP, Adamek L, Pluta M, Taszkun I, Gołyński M, Rozwód A, Sitkowski W. Assessment of serum levels of allergen-specific immunoglobulin E in different seasons and breeds in healthy horses.. Pol J Vet Sci 2014;17(2):331-7.
    doi: 10.2478/pjvs-2014-0045pubmed: 24988860google scholar: lookup
  131. Morgan EE, Miller WH Jr, Wagner B. A comparison of intradermal testing and detection of allergen-specific immunoglobulin E in serum by enzyme-linked immunosorbent assay in horses affected with skin hypersensitivity.. Vet Immunol Immunopathol 2007 Dec 15;120(3-4):160-7.
    doi: 10.1016/j.vetimm.2007.08.007pubmed: 17888519google scholar: lookup
  132. Lorch G, Hillier A, Kwochka KW, Saville WJ, Kohn CW, LeRoy BE. Comparison of immediate intradermal test reactivity with serum IgE quantitation by use of a radioallergosorbent test and two ELISA in horses with and without atopy.. J Am Vet Med Assoc 2001 Apr 15;218(8):1314-22.
    doi: 10.2460/javma.2001.218.1314pubmed: 11330620google scholar: lookup
  133. Enck KM, Lee KW, McKinney BH, Blankenship KD, Montesano C. Detection and inhibition of IgE antibodies reactive with cross-reactive carbohydrate determinants in an ELISA for allergen-specific IgE in horses.. Vet Dermatol 2021 Dec;32(6):685-e184.
    pubmed: 33956389doi: 10.1111/vde.12963google scholar: lookup
  134. Loeffler A, Herrick D, Allen S, Littlewood JD. Long-term management of horses with atopic dermatitis in southeastern England: a retrospective questionnaire study of owners' perceptions.. Vet Dermatol 2018 Dec;29(6):526-e176.
    doi: 10.1111/vde.12685pubmed: 30175879google scholar: lookup
  135. Mueller RS, Jensen-Jarolim E, Roth-Walter F, Marti E, Janda J, Seida AA, DeBoer D. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.. Allergy 2018 Oct;73(10):1989-1999.
    doi: 10.1111/all.13464pubmed: 29675865google scholar: lookup
  136. Stepnik CT, Outerbridge CA, White SD, Kass PH. Equine atopic skin disease and response to allergen-specific immunotherapy: a retrospective study at the University of California-Davis (1991-2008).. Vet Dermatol 2012 Feb;23(1):29-35, e7.
    doi: 10.1111/j.1365-3164.2011.01001.xpubmed: 21777308google scholar: lookup
  137. Craig C, Wilkes R, Munguia N, Dorr M, Marsella R. IL-31: A mediator of pruritus in horses.. Vet. Dermatol. 2020;31:87.
  138. Olomski F, Fettelschoss V, Jonsdottir S, Birkmann K, Thoms F, Marti E, Bachmann MF, Kündig TM, Fettelschoss-Gabriel A. Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch.. Allergy 2020 Apr;75(4):862-871.
    doi: 10.1111/all.14145pmc: PMC7217000pubmed: 31816097google scholar: lookup
  139. Fettelschoss-Gabriel A, Fettelschoss V, Thoms F, Giese C, Daniel M, Olomski F, Kamarachev J, Birkmann K, Bühler M, Kummer M, Zeltins A, Marti E, Kündig TM, Bachmann MF. Treating insect-bite hypersensitivity in horses with active vaccination against IL-5.. J Allergy Clin Immunol 2018 Oct;142(4):1194-1205.e3.
    doi: 10.1016/j.jaci.2018.01.041pubmed: 29627082google scholar: lookup
  140. Fettelschoss-Gabriel A, Fettelschoss V, Olomski F, Birkmann K, Thoms F, Bühler M, Kummer M, Zeltins A, Kündig TM, Bachmann MF. Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.. Allergy 2019 Mar;74(3):572-582.
    doi: 10.1111/all.13659pmc: PMC6587569pubmed: 30402930google scholar: lookup
  141. Visser M, Cleaver D, Cundiff B, King V, Sture G. Oclacitinib maleate (Apoquel) dose determination in horses with naturally occurring allergic dermatitis.. J. Vet. Int. Med. 2020;34:2978.
  142. Collard W, Thorn J, Smith S, Feenstra K. Pharmacokinetics of oclacitinib following oral and intravenous administration to horses.. J. Vet. Int. Med. 2020;34:2979.

Citations

This article has been cited 15 times.
  1. Noli C, Varina A, Barbieri C, Pirola A, Olivero D. Analysis of Intestinal Microbiota and Metabolic Pathways before and after a 2-Month-Long Hydrolyzed Fish and Rice Starch Hypoallergenic Diet Trial in Pruritic Dogs. Vet Sci 2023 Jul 21;10(7).
    doi: 10.3390/vetsci10070478pubmed: 37505882google scholar: lookup
  2. Chrobak-Chmiel D, Golke A, Kwiecień E, Biegańska MJ, Dembele K, Dziekiewicz-Mrugasiewicz M, Czopowicz M, Kizerwetter-Świda M, Rzewuska M. Is Vitamin D3 a Worthy Supplement Protecting against Secondary Infections in Dogs with Atopic Dermatitis?. Pathogens 2023 Jan 15;12(1).
    doi: 10.3390/pathogens12010145pubmed: 36678493google scholar: lookup
  3. Adam GO, Park YG, Cho JH, Choi J, Oh HG. Detecting common allergens in dogs with atopic dermatitis in South Korean Provinces using a serological immunoglobulin E-specific allergen test. Vet World 2022 Aug;15(8):1996-2003.
    doi: 10.14202/vetworld.2022.1996-2003pubmed: 36313853google scholar: lookup
  4. Messina L, Bruno F, Licata P, Paola DD, Franco G, Marino Y, Peritore AF, Cuzzocrea S, Gugliandolo E, Crupi R. Snail Mucus Filtrate Reduces Inflammation in Canine Progenitor Epidermal Keratinocytes (CPEK). Animals (Basel) 2022 Jul 21;12(14).
    doi: 10.3390/ani12141848pubmed: 35883395google scholar: lookup
  5. Segarra S, Naiken T, Garnier J, Hamon V, Coussay N, Bernard FX. Enhanced In Vitro Expression of Filaggrin and Antimicrobial Peptides Following Application of Glycosaminoglycans and a Sphingomyelin-Rich Lipid Extract. Vet Sci 2022 Jun 27;9(7).
    doi: 10.3390/vetsci9070323pubmed: 35878340google scholar: lookup
  6. Sordillo A, Heldrich J, Turcotte R, Sheth RU. An Indole-Rich Postbiotic Reduces Itching in Dogs: A Randomized, Double-Blinded Placebo-Controlled Study. Animals (Basel) 2025 Jul 9;15(14).
    doi: 10.3390/ani15142019pubmed: 40723482google scholar: lookup
  7. Park GW, Ataallahi M, Park KH. Stress level in companion dogs with and without atopic dermatitis. J Anim Sci Technol 2025 Mar;67(2):468-476.
    doi: 10.5187/jast.2024.e28pubmed: 40264528google scholar: lookup
  8. Gober M, Amodie D, Mellencamp M, Hillier A. Long term use of lokivetmab (Cytopoint®) in atopic dogs. BMC Vet Res 2025 Mar 26;21(1):203.
    doi: 10.1186/s12917-025-04645-8pubmed: 40133889google scholar: lookup
  9. Ardicli S, Ardicli O, Yazici D, Pat Y, Babayev H, Xiong P, Zeyneloglu C, Garcia-Sanchez A, Shi LL, Viscardi OG, Skolnick S, Ogulur I, Dhir R, Jutel M, Agache I, Janda J, Pali-Schöll I, Nadeau KC, Akdis M, Akdis CA. Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needs. Allergy 2024 Dec;79(12):3238-3268.
    doi: 10.1111/all.16343pubmed: 39417247google scholar: lookup
  10. Kim YS, Ha SE, Bae H, Lee D, Yu D, Kim GS. Clinical efficacy of membrane-free stem cell extracts for the treatment of canine atopic dermatitis. Vet Med (Praha) 2022 Jun;67(9):463-470.
    doi: 10.17221/136/2021-VETMEDpubmed: 38715969google scholar: lookup
  11. Segarra S, Bošnjak I, Mioč I, Čurčija B, Csik VA, Krešić S, Romero-Rueda J, Rodríguez A, Martínez-Puig D. Yeast-Derived Nucleotides Enhance Fibroblast Migration and Proliferation and Provide Clinical Benefits in Atopic Dermatitis. Int J Mol Sci 2024 Mar 1;25(5).
    doi: 10.3390/ijms25052890pubmed: 38474135google scholar: lookup
  12. Tate DE, Tanprasertsuk J, Jones RB, Maughan H, Chakrabarti A, Khafipour E, Norton SA, Shmalberg J, Honaker RW. A Randomized Controlled Trial to Evaluate the Impact of a Novel Probiotic and Nutraceutical Supplement on Pruritic Dermatitis and the Gut Microbiota in Privately Owned Dogs. Animals (Basel) 2024 Jan 30;14(3).
    doi: 10.3390/ani14030453pubmed: 38338095google scholar: lookup
  13. Fernandes B, Alves S, Schmidt V, Bizarro AF, Pinto M, Pereira H, Marto J, Lourenço AM. Primary Prevention of Canine Atopic Dermatitis: Breaking the Cycle-A Narrative Review. Vet Sci 2023 Nov 16;10(11).
    doi: 10.3390/vetsci10110659pubmed: 37999481google scholar: lookup
  14. Kong J, Yang Y, Liu Y, Cao Y, Qiu J, Sun P, Cao X. The Pharmacokinetic and Absolute Bioavailability of Cyclosporine (Atopica for Cats(®)) in Cats. Vet Sci 2023 Jun 18;10(6).
    doi: 10.3390/vetsci10060399pubmed: 37368785google scholar: lookup
  15. Segarra S, Sanmiguel D, Zuriaga E, Leclerc S, Cabañas J, Seigneuric E, Miquel A, Vázquez A, Ferrer L. Sphingomyelin-Rich Lipid Extract Collar for Canine Atopic Dermatitis. Vet Sci 2023 Jun 7;10(6).
    doi: 10.3390/vetsci10060389pubmed: 37368775google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.